Cassava Pulls Plug on Alzheimer’s Drug Simufilam 🔗 Access full article via Medscape NeurologyCassava Sciences said it will stop all trials of its Alzheimer’s disease drug after it failed a late-stage study, sending shares of the drug developer plummeting 83% in… Reuters Health Information Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
